RUDN Journal of MedicineRUDN Journal of MedicineВестник Российского университета дружбы народов. Серия: Медицина2313-02452313-0261Peoples’ Friendship University of Russia named after Patrice Lumumba (RUDN University)1663610.22363/2313-0245-2017-21-2-163-170ArticlesСтатьиResearch ArticlePATENT DUCTUS ARTERIOSUS - GOOD AND EVIL IN ONE VESSELОТКРЫТЫЙ АРТЕРИАЛЬНЫЙ ПРОТОК - «ДОБРО И ЗЛО В ОДНОМ СОСУДЕ» (обзор литературы)BokeryaE LБокерияЕ Лkonovalov_oe@rudn.universityDegtyarevaE AДегтяреваЕ А

Дегтярева Елена Александровна - д.м.н., профессор. ВГАО ВО Российский университет дружбы народов

dib6@yandex.ruRUDN University (Peoples’ Friendship University of Russia), Moscow, RussiaВГАО ВО Российский университет дружбы народов, Москва, Россия15122017212VOL 21, NO2 (2017)ТОМ 21, №2 (2017)16317009092017Copyright ©; 2017, Bokerya E.L., Degtyareva E.A.Copyright ©; 2017, Бокерия Е.Л., Дегтярева Е.А.2017Bokerya E.L., Degtyareva E.A.Бокерия Е.Л., Дегтярева Е.А.http://creativecommons.org/licenses/by/4.0https://journals.rudn.ru/medicine/article/view/16636

Literature review discusses questions of hemodynamic significance of Patent Ductus Arte-riosus, methods of its surgical and drug (non-surgical) treatment and features in premature newborns.

В обзоре обсуждаются вопросы гемодинамической значимости открытого артериального про-тока, методы медикаментозного и хирургического лечения, особенности у недоношенных детей.

Patent Ductus Arteriosushemodynamic significancenewborn babyоткрытый артериальный протокгемодинамическая значимостьноворож-денный ребенокBokeria L. A. & Shatalov K. V. Pediatric Cardiosurgery. A guide for doctors. M.: FGBU «NCSSH im. A.N. Bakuleva» MZ RF. 2016. 864 s.Бокерия Л.А., Шаталов К.В. Детская кардиохирургия. Руководство для врачей. М.: ФГБУ «НЦССХ им. А.Н. Бакулева» МЗ РФ. 2016. 864 с.Heymann M. A., Rudolph A. M. & Silverman N. H. Closure of the ductusarteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med. 1976. Vol. 295. Р. 530—533.Heymann M.A., Rudolph A.M., Silverman N.H. Closure of the ductusarteriosus in premature infants by inhibition of prostaglandin synthesis // N Engl J Med. 1976. Vol. 295. Р. 530-533.Patel J., Marks K. A., Roberts I., Azzopardi D. & Edwards A. D. Ibuprofen treatment of patent ductus arteriosus. Lancet. 1995. Vol. 346. № 8969. Р. 255.Patel J., Marks K.A., Roberts I., Azzopardi D., Edwards A.D. Ibuprofen treatment of patent ductus arteriosus // Lancet. 1995. Vol. 346. № 8969. Р. 255.Volodin N. N. & Baybarina E. N. Protocol for the management of premature infants with a hemo-dynamically significant functioning arterial duct: Methodological recommendations. М.: РАСПМ, 2010. 28 s.Володин Н.Н., Байбарина Е.Н. Протокол ведения недоношенных детей с гемодинамически значимым функционирующим артериальным протоком: Методические рекомендации. М.: РАСПМ, 2010. 28 с.Nemerofsky S. L. et al. The ductus arteriosus rarely requires treatment in infants > 1000 grams. Am J Perinatol. 2008. № 25. Р. 661—666.Nemerofsky S.L. et al. The ductus arteriosus rarely requires treatment in infants > 1000 grams //Am J Perinatol. 2008. № 25. Р. 661-666.Herrman Ket. Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit. Arch Dis Child Fetal Neonatal Ed. 2009. № 94. Р. F48—50.Herrman Ket. Spontaneous closure of the patent ductus arteriosus in very low birth weight infants following discharge from the neonatal unit // Arch Dis Child Fetal Neonatal Ed. 2009. № 94. Р. F48-50.Fowlie P. W., Davis P. G. & McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev. 2009. Р. 419—471.Fowlie P.W., Davis P.G., McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants // Cochrane Database Syst Rev. 2009. Р. 419-471.Mosalli R., Alfaleh K. & Paes B. Role of prophylactic surgical ligation of patent ductus arteriosus in extremely low birth weight infants: Systematic review and implications for clinical practice. Ann Pediatr Cardiol. 2009. № 2. Р. 120—126.Mosalli R., Alfaleh K., Paes B. Role of prophylactic surgical ligation of patent ductus arteriosus in extremely low birth weight infants: Systematic review and implications for clinical practice // Ann Pediatr Cardiol. 2009. № 2. Р. 120-126.Clyman R., Cassady G., Kirklin J. K., Collins M. & Philips J. B. The role of patent ductusarte¬riosus ligation in broncho pulmonary dysplasia: reexamining a randomized controlled trial. J Pediatr. 2009. № 154. Р. 873—876.Clyman R., Cassady G., Kirklin J.K., Collins M., Philips J.B. The role of patent ductusarteriosus ligation in broncho pulmonary dysplasia: reexamining a randomized controlled trial // J Pediatr. 2009. № 154. Р. 873-876.Sinha B. Controversies in Management of Patent Ductus Arterious in the Preterm Infant. J Pulmon Resp Med. 2009. № 13. Р. 7.Sinha B. Controversies in Management of Patent Ductus Arterious in the Preterm Infant // J Pulmon Resp Med. 2009. № 13. Р. 7.Van Overmeire B., Van de Broek H., Van Laer P., Weyler J. & Vanhaesebrouck P. Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory dis-tress syndrome. J Pediatr. № 138. Р. 205—211.Van Overmeire B., Van de Broek H., Van Laer P., Weyler J., Vanhaesebrouck P. Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome // J Pediatr. № 138. Р. 205-211.Hammerman C., Bin-Nun A., Markovitch E., Schimmel M. S., Kaplan M., et al. Ductal closure with paracetamol: a surprising new approach to patent ductusarteriosus treatment. Pediatrics. 2011. № 128. Р. 1618—1621.Hammerman C., Bin-Nun A., Markovitch E., Schimmel M.S., Kaplan M., et al. Ductal closure with paracetamol: a surprising new approach to patent ductusarteriosus treatment // Pediatrics. 2011. № 128. Р. 1618-1621.Van der Lugt N.M., Lopriore E., Bökenkamp R., Smits-Wintjens V.E., Steggerda S. J., et al. Re-peated courses of ibuprofen are effective in closure of a patentductusarteriosus. Eur J Pediatr. 2012. № 171. Р. 1673—1677.Van der Lugt N.M., Lopriore E., Bökenkamp R., Smits-Wintjens V.E., Steggerda S.J., et al. Repeated courses of ibuprofen are effective in closure of a patentductusarteriosus // Eur J Pediatr. 2012. № 171. Р. 1673-1677.Ohlsson A., Walia R. & Shah S. S. Ibuprofen for the treatment of patent ductus arteriosus in pre-term or low birth weight (or both) infants. Cochrane Database of Systematic Reviews 2015, Issue 2. Art. No.: CD003481. DOI: 10.1002/14651858.CD003481.pub6.Ohlsson A., Walia R., Shah S.S. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Database of Systematic Reviews 2015, Issue 2. Art. No.: CD003481. DOI: 10.1002/14651858.CD003481.pub6.Dolk H., Loane M. & Garne E. Congenital heart defects in Europe: prevalence and perinatal mor-tality, 2000 to 2005. Circulation. 2011. Vol. 123. № 8. Р. 841—849.Dolk H., Loane M., Garne E. Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005 // Circulation. 2011. Vol. 123. № 8. Р. 841-849.Tanner K., Sabrine N. & Wren C. Cardiovascular malformations among preterm infants. Pediat-rics. 2005. Vol. 116. № 6. Р. 833—838.Tanner K., Sabrine N., Wren C. Cardiovascular malformations among preterm infants // Pediatrics. 2005. Vol. 116. № 6. Р. 833-838.Kemper A. R., Mahle W. T., Martin G. R., Cooley W. C., Kumar P., Morrow W. R., Kelm K., Pearson G. D., Glidewell J., Grosse S. D. & Howell R. R. Strategies for Implementing Screening for Critical Congenital Heart Disease. Pediatrics. 2011. Vol. 128. Р. 1259—1267.Kemper A.R., Mahle W.T., Martin G.R., Cooley W.C., Kumar P., Morrow W.R., Kelm K., Pearson G.D., Glidewell J., Grosse S.D. and Howell R.R. Strategies for Implementing Screening for Critical Congenital Heart Disease // Pediatrics. 2011. Vol. 128. Р. 1259-1267.Lhost J. J., Goetz E. M., Belling J. D., vanRoojen W. M., Spicer G. & Hokanson J. S. Pulse¬oximetry screening for critical congenital heart disease in planned out-of-hospitalbirths. J Pediatr. 2014. Vol. 165. № 3. P. 485—489.Lhost J.J., Goetz E.M., Belling J.D., vanRoojen W.M., Spicer G., Hokanson J.S. Pulseoximetry screening for critical congenital heart disease in planned out-of-hospitalbirths // J Pediatr. 2014. Vol. 165. № 3. P. 485-489.Mahle W. T., Newburger J. W., Matherne G. P., Smith F. C., Hoke T. R., Koppel R., Gid¬ding S. S., Beekman III R. H. & Grosse S. D. Role of Pulse Oximetry in Examining Newborns for Con-genital Heart Disease: A Scientific Statement from the AHA and AAP. Pediatrics. 2009. Vol. 124. P. 823—836.Mahle W.T., Newburger J.W., Matherne G.P., Smith F.C., Hoke T.R., Koppel R., Gidding S.S., Beekman III R.H. and Grosse S.D. Role of Pulse Oximetry in Examining Newborns for Congenital Heart Disease: A Scientific Statement from the AHA and AAP // Pediatrics. 2009. Vol. 124. P. 823-836.Shkol'nikova M. A., Bokerija E. L., Degtjareva E. A., Il’in V. N. & Sharykin E. S. Neonatal screening to identify critical congenital heart disease. Guidelines № 12. М.: ООО «М-Арт». 2012. 36 с.Школьникова М.А., Бокерия Е.Л., Дегтярева Е.А., Ильин В.Н., Шарыкин Е.С. Неонатальный скрининг с целью выявления критических врожденных пороков сердца. Методические рекомендации № 12. М.: ООО «М-Арт». 2012. 36 с.